BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24719242)

  • 1. High resolution in vivo characterization of apparent diffusion coefficient at the tumor-stromal boundary of breast carcinomas: a pilot study to assess treatment response using proximity-dependent diffusion-weighted imaging.
    McLaughlin RL; Newitt DC; Wilmes LJ; Jones EF; Wisner DJ; Kornak J; Proctor E; Joe BN; Hylton NM
    J Magn Reson Imaging; 2014 May; 39(5):1308-13. PubMed ID: 24719242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response.
    Wilmes LJ; McLaughlin RL; Newitt DC; Singer L; Sinha SP; Proctor E; Wisner DJ; Saritas EU; Kornak J; Shankaranarayanan A; Banerjee S; Jones EF; Joe BN; Hylton NM
    Acad Radiol; 2013 May; 20(5):581-9. PubMed ID: 23570936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
    Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
    Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of tumor morphology on diffusion-weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWI.
    Barentsz MW; Taviani V; Chang JM; Ikeda DM; Miyake KK; Banerjee S; van den Bosch MA; Hargreaves BA; Daniel BL
    J Magn Reson Imaging; 2015 Dec; 42(6):1656-65. PubMed ID: 25914178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.
    Newitt DC; Zhang Z; Gibbs JE; Partridge SC; Chenevert TL; Rosen MA; Bolan PJ; Marques HS; Aliu S; Li W; Cimino L; Joe BN; Umphrey H; Ojeda-Fournier H; Dogan B; Oh K; Abe H; Drukteinis J; Esserman LJ; Hylton NM;
    J Magn Reson Imaging; 2019 Jun; 49(6):1617-1628. PubMed ID: 30350329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of diffusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy.
    Atuegwu NC; Arlinghaus LR; Li X; Welch EB; Chakravarthy BA; Gore JC; Yankeelov TE
    Magn Reson Med; 2011 Dec; 66(6):1689-96. PubMed ID: 21956404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
    Liu C; Liang C; Liu Z; Zhang S; Huang B
    Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy.
    Spick C; Bickel H; Pinker K; Bernathova M; Kapetas P; Woitek R; Clauser P; Polanec SH; Rudas M; Bartsch R; Helbich TH; Baltzer PA
    NMR Biomed; 2016 Oct; 29(10):1445-53. PubMed ID: 27553252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results.
    Jin G; An N; Jacobs MA; Li K
    Acad Radiol; 2010 Apr; 17(4):456-63. PubMed ID: 20207316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the diagnostic performances of diffusion parameters in diffusion weighted imaging and diffusion tensor imaging of breast lesions.
    Cakir O; Arslan A; Inan N; Anık Y; Sarısoy T; Gumustas S; Akansel G
    Eur J Radiol; 2013 Dec; 82(12):e801-6. PubMed ID: 24099642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
    Karan B; Pourbagher A; Torun N
    J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer.
    Shin HJ; Kim SH; Lee HJ; Gong G; Baek S; Chae EY; Choi WJ; Cha JH; Kim HH
    NMR Biomed; 2016 Aug; 29(8):1070-8. PubMed ID: 27332719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging of the high-risk breast: Apparent diffusion coefficient values and their relationship to breast density.
    O'Flynn EA; Wilson RM; Allen SD; Locke I; Scurr E; deSouza NM
    J Magn Reson Imaging; 2014 Apr; 39(4):805-11. PubMed ID: 24038529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of ADC Difference Value on Pre-neoadjuvant Chemotherapy MRI for Response Evaluation of Breast Cancer.
    Choi BB
    Technol Cancer Res Treat; 2021; 20():15330338211039129. PubMed ID: 34519583
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications.
    Partridge SC; McDonald ES
    Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):601-24. PubMed ID: 23928248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
    Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
    J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diffusion-weighted breast imaging. Clinical implementation procedure].
    Wenkel E; Uder M; Janka R
    Radiologe; 2014 Mar; 54(3):224-32. PubMed ID: 24570109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings.
    Woodhams R; Kakita S; Hata H; Iwabuchi K; Umeoka S; Mountford CE; Hatabu H
    AJR Am J Roentgenol; 2009 Jul; 193(1):260-6. PubMed ID: 19542422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.